Back

Khorasan wheat products' consumption and non-alcoholic fatty liver disease (NAFLD): a randomized, double-blind trial

6 April 2017 (08:30 - 18:00)
Organised by:
Congress Presentation Part of: Poster Session I - Thursday 08:30 - 18:00 - Diabetes/ Lipids/Obesity/Nutrition_Part 3 Nutrition EAPC Premium Access EuroPrevent 2017

About the speaker

Photo
Mrs Monica Dinu

University of Florence, Florence (Italy)

12 More presentations in this session

Presentation thumbnail
Presentation thumbnail
Professor D. Panagiotakos (Athens, GR)
Abstract
Presentation thumbnail
Doctor A. Horina (Graz, AT)
Abstract Slides
Presentation thumbnail
Professor A. Witkowska (Bialystok, PL)
Abstract
Presentation thumbnail
Doctor K. Lehnert (Greifswald, DE)
Abstract

Access the full session

Session thumbnail
Poster Session I - Thursday 08:30 - 18:00 - Diabetes/ Lipids/Obesity/Nutrition_Part 3

The Event

Event poster

EuroPrevent 2017

6 April 2017 08:30 CET
You may be interested in
thumbnail
Congress Presentation
Effects of sodium-glucose contrasporter-2 inhibitors and glucagon-like peptide-1 receptor agonists on vascular function and liver steatosis in diabetes
27 August 2023
thumbnail
Congress Presentation
impact of different cardiometabolic risk factors in MASLD: rethinking overweight/obesity criteria.
26 April 2024
thumbnail
Congress Presentation
Prevalence of non-alcoholic fatty liver disease measured by controlled attenuation parameter in patients with heart failure according to the left ventricular ejection fraction
29 June 2021
thumbnail
Congress Presentation
Antihypertensive drugs in experimental NAFLD as the first step to the establishment of criteria for choosing appropriate treatment of hypertension in NAFLD carriers
2 September 2019

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources